MRT68921 Dual Autophagy Kinase ULK1/2 Inhibitor: Mechanism, Evidence, and Application

Executive Summary: MRT68921 is a highly selective dual inhibitor of the serine/threonine kinases ULK1 and ULK2, with IC50 values of 2.9 nM and 1.1 nM respectively, enabling robust blockade of autophagy initiation (APExBIO, product page). The compound specifically inhibits ATG13 phosphorylation and LC3 flux in wild-type cells, but not in cells expressing ULK1-M92T mutants, confirming on-target activity (Egan et al., 2015, see DOI). While MRT68921 also inhibits TBK1/IKK and AMPK-related kinases by >80%, these off-targets do not mediate its autophagy blocking effect (APExBIO; Park et al., 2023, DOI). The compound is insoluble in water/ethanol, but dissolves at ≥2.18 mg/mL in DMSO under warming and sonication (APExBIO). MRT68921 is intended for research use only and is not approved for therapeutic or diagnostic use.

Biological Rationale

Autophagy is a conserved cellular process for degrading and recycling damaged or long-lived proteins and organelles, essential for homeostasis and adaptation to stress (Park et al., 2023). Initiation of autophagy depends on the activation of the ULK1/2 kinase complex, which transduces upstream signals such as mTORC1 inhibition and energy stress. Recent evidence shows that AMP-activated protein kinase (AMPK) can negatively regulate ULK1 activity, contrary to earlier models (Park et al., 2023). Inhibition of ULK1/2 with small molecules like MRT68921 allows precise, temporal dissection of autophagy induction and downstream flux. These insights are critical for research on cancer, neurodegenerative disease, and metabolic disorders where autophagy plays nuanced roles (contrast: this article provides updated mechanistic clarity on AMPK-ULK1 regulation).

Mechanism of Action of MRT68921 dual autophagy kinase ULK1/2 inhibitor

MRT68921 is a reversible, ATP-competitive inhibitor targeting the kinase domains of ULK1 and ULK2, with reported IC50 values of 2.9 nM and 1.1 nM, respectively, measured via in vitro kinase assays at 25°C in Tris-HCl buffer (pH 7.5) (APExBIO). By inhibiting ULK1/2, MRT68921 suppresses phosphorylation of the ULK1 substrate ATG13, a critical step in autophagy initiation (Egan et al., 2015). This leads to downstream reductions in LC3-II formation and autophagosome maturation, measurable by LC3 flux assay. Importantly, mutant ULK1 (M92T) confers resistance to MRT68921, confirming specific kinase targeting (contrast: this article specifies the role of resistance mutations in on-target validation). Although MRT68921 can inhibit TBK1/IKK and several AMPK-related kinases in biochemical assays, these kinases are not essential for autophagy inhibition in this context (Park et al., 2023).

Evidence & Benchmarks

• MRT68921 inhibits ULK1 kinase activity with an in vitro IC50 of 2.9 nM at 25°C (APExBIO, product page).
• MRT68921 blocks ATG13 phosphorylation and LC3 flux in wild-type cells, but not in ULK1-M92T mutants (Egan et al., 2015, DOI).
• AMPK activation inhibits ULK1 and autophagy, rather than promoting it, counter to previous dogma (Park et al., 2023, DOI).
• MRT68921 inhibits TBK1/IKK and AMPK-related kinases by >80% in vitro, but these are not implicated in autophagy blockade (APExBIO, product page).
• No in vivo animal data or clinical trial results are available for MRT68921 as of 2024 (APExBIO, product page).

Applications, Limits & Misconceptions

Primary Applications:

• Dissecting autophagy signaling pathways in cell culture models.
• Validating ULK1/2-dependent steps using ATG13 phosphorylation and LC3 flux assays.
• Preclinical studies in cancer, neurodegeneration, or metabolic disease research focused on autophagy modulation (contrast: this article expands on mechanistic and workflow parameters).

Common Pitfalls or Misconceptions

• MRT68921 is insoluble in water and ethanol; improper solvent use leads to precipitation and loss of activity. DMSO is required for dissolution at concentrations ≥2.18 mg/mL, with gentle warming and ultrasonic treatment (APExBIO).
• Off-target kinase inhibition (e.g., TBK1/IKK, AMPK-related kinases) does not equate to autophagy blockade in most cell models; phenotypes should be confirmed by ATG13/LC3 assays (Park et al., 2023).
• Lack of in vivo or clinical data: MRT68921 is for research use only and is not validated for animal or therapeutic applications.
• Not all autophagy phenotypes are ULK1/2-dependent; alternate pathways may sustain autophagy under certain stress conditions.
• Long-term storage in solution can result in degradation; fresh DMSO solutions are recommended for each experiment (APExBIO).

Workflow Integration & Parameters

MRT68921 (SKU B6174) from APExBIO is supplied as a hydrochloride salt (C25H34N6O·xHCl, MW 434.58) and should be stored at -20°C in a desiccated environment. For in vitro use, dissolve in DMSO (≥2.18 mg/mL) with gentle warming and sonication. Filter-sterilize solutions for cell culture applications. Typical working concentrations for autophagy inhibition range from 10 nM to 1 µM, depending on cell type and assay sensitivity.

Monitor ATG13 phosphorylation and LC3-II flux by Western blot or immunofluorescence as primary readouts. Use negative controls (e.g., ULK1-M92T mutants) for specificity. For troubleshooting, consult the product documentation and optimized protocols (contrast: this article details pitfalls and off-target clarifications beyond workflow tips).

Conclusion & Outlook

MRT68921 is a robust, selective dual ULK1/2 inhibitor for dissecting autophagy signaling in vitro. Its nanomolar potency and validated on-target readouts provide a high-confidence toolkit for preclinical research. Users must be aware of its solubility and storage constraints, lack of in vivo data, and the necessity of confirming autophagy inhibition via ATG13 and LC3 assays. As ongoing research (e.g., Park et al., 2023) redefines the regulatory network of autophagy, MRT68921 will be essential for mapping dynamic kinase interactions and cellular adaptation strategies. For full details and ordering, see the MRT68921 dual autophagy kinase ULK1/2 inhibitor page from APExBIO.